Antibiotice (BVB:ATB), the first pharma company to join ARIR

31/07/2019 / Comments Off on Antibiotice (BVB:ATB), the first pharma company to join ARIR

News newsen

Bucharest, July 31, 2019The Romanian Investor Relations Association (ARIR) is delighted to associate with Antibiotice (BVB:ATB), one of the most important Romanian manufacturers of generic drugs from the pharmaceutical industry, company listed on the Bucharest Stock Exchange (BVB) since 1997.

Ioan Nani, CEO Antibiotice:
“We are among the first companies listed on the BVB and we have always been focused on developing and increasing transparency towards our shareholders. The association with ARIR, together with the largest listed companies, supports our strategy to improve the quality of investor relations and to create value for our shareholders. We are delighted to be part of a new and dynamic Romanian capital markets’ community, a market we want to become stronger.”

Antibiotice has in his portfolio over 150 generic drugs for patients with infectious diseases but also for those suffering from cardiovascular, dermatological, digestive, central nervous system diseases and for women’s health. It is an important partner of the hospitals pharmaceutical market and has at the same time a portfolio for prophylaxis and for increasing the quality of life (food supplements, medical devices and OTCs).
Antibiotice has an active global presence, exporting in over 70 countries. At the same time, Antibiotice is the global leader in Nystatin production and an international reference standard for this active substance.

Daniela Șerban, ARIR President:
“Antibiotice becomes the 15th member of ARIR and the first from the pharmaceutical industry. We are pleased to see the scale and diversity that the only association for investor relations in Romania is gaining. In order to improve communication between companies and investors, sectoral diversity within the association contributes to increased expertise and to a better implementation of best practices in investor communication and corporate governance in various industries. Increasing transparency and social responsibility are priorities of our community.”

Antibiotice joins an elite group of companies, members of the Association, such as Bucharest Stock Exchange, ALRO, Electrica, Electromagnetica, Franklin Templeton, Hidroelectrica, Nuclearelectrica, OMV Petrom, Teraplast and Transelectrica.

ARIR was set-up in November 2018 and has as members listed companies, companies with potential to become listed companies, fund managers, IR professionals as well as consultants. In ARIR are invited to join: as Associate Members – listed companies, pre-IPO or bond issuers, as Affiliate Members – other organisations than listed companies, pre-IPO or bond issuers, and as Professional Members – individuals with experience in investor relations. ARIR members have access to exclusive content and trainings tailored to their needs and IR objectives, and participate at projects aimed to develop the capital market.

Photo: Remus Agatinei